Literature DB >> 16126043

Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit.

C Mary Healy1, Carol J Baker, Elena Zaccaria, Judith R Campbell.   

Abstract

OBJECTIVES: We assessed the impact of intravenous fluconazole prophylaxis (FP) in extremely low birth weight (ELBW [<1000 g]) infants on the incidence of and outcome from invasive candidiasis (IC) in all infants admitted to a neonatal intensive care unit (NICU). STUDY
DESIGN: Beginning April 1, 2002, FP was given to ELBW infants aged < 5 days admitted to the NICU of Woman's Hospital of Texas. Infants in NICU in whom IC developed during the first 2 years of FP (FP period) were compared with those with IC during 2000-2001.
RESULTS: During 2000-2001 and the FP period, the incidence of IC in ELBW infants decreased from 7% (15 of 206) to 2% (5 of 240) (P=.01), and the IC-related mortality rate decreased from 12% (4 of 33) to 0 (0 of 40) (P=.04); the incidence of IC increased from 0.1% (4 of 2806) to 0.2% (8 of 3372) in infants of birth weight > or = 1000 g (P=.06), and no IC-related deaths occurred. During the FP period, IC developed in older infants (24 vs 12 days; P=.12) who had similar risk factors for IC.
CONCLUSION: Invasive candidiasis occurred in our NICU in spite of FP and shifted to bigger, more mature infants who had a better outcome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16126043     DOI: 10.1016/j.jpeds.2005.04.016

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  24 in total

Review 1.  Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.

Authors:  Jemma Cleminson; Nicola Austin; William McGuire
Journal:  Cochrane Database Syst Rev       Date:  2015-10-24

2.  Is routine fluconazole prophylaxis necessary in preterm infants?

Authors:  José Antonio Morales-Molina; Javier Mateu-de Antonio; Santiago Grau; Sonia Luque; Nuria Berenguer
Journal:  Pharm World Sci       Date:  2006-09-27

3.  Empiric guidelines for treatment of Candida infection in high-risk neonates.

Authors:  Renato S Procianoy; Mariluce V Enéas; Rita C Silveira
Journal:  Eur J Pediatr       Date:  2006-03-14       Impact factor: 3.183

4.  First, do no harm.

Authors:  Daniel K Benjamin
Journal:  Pediatrics       Date:  2008-04       Impact factor: 7.124

Review 5.  Candida infections of the genitourinary tract.

Authors:  Jacqueline M Achkar; Bettina C Fries
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

6.  The diagnostic performance of the beta-glucan assay in the detection of intra-amniotic infection with Candida species.

Authors:  Percy Pacora; Roberto Romero; Offer Erez; Eli Maymon; Bogdan Panaitescu; Juan Pedro Kusanovic; Adi L Tarca; Chaur-Dong Hsu; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2017-12-27

Review 7.  Triazole use in the nursery: fluconazole, voriconazole, posaconazole, and ravuconazole.

Authors:  Kevin Watt; Paolo Manzoni; Michael Cohen-Wolkowiez; Stefano Rizzollo; Elena Boano; Evelyne Jacqz-Aigrain; Daniel K Benjamin
Journal:  Curr Drug Metab       Date:  2013-02       Impact factor: 3.731

Review 8.  Antifungal agents in neonates: issues and recommendations.

Authors:  Benito Almirante; Dolors Rodríguez
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

9.  Selective fluconazole prophylaxis in high-risk babies to reduce invasive fungal infection.

Authors:  Brian A McCrossan; Elaine McHenry; Fiona O'Neill; Grace Ong; David G Sweet
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-04-25       Impact factor: 5.747

Review 10.  Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.

Authors:  Jessica K Roberts; Chris Stockmann; Jonathan E Constance; Justin Stiers; Michael G Spigarelli; Robert M Ward; Catherine M T Sherwin
Journal:  Clin Pharmacokinet       Date:  2014-07       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.